Me. Harper et al., VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) EXPRESSION IN PROSTATIC TUMORS AND ITS RELATIONSHIP TO NEUROENDOCRINE CELLS, British Journal of Cancer, 74(6), 1996, pp. 910-916
Vascular endothelial growth factor (VEGF) expression was examined by i
mmunohistochemistry in 45 prostatic carcinoma specimens and ten benign
prostatic tumours (BPH). The majority of carcinoma specimens exhibite
d cytoplasmic staining for VEGF and showed a trend of increasing expre
ssion with dedifferentiation (2p=0.003). Immunoreactive VEGF was also
seen in the prostatic carcinoma cell lines, the order of staining inte
nsity was PC3>DU145>LNCaP. Intense granular cytoplasmic staining for V
EGF was observed in neuroendocrine-like cells which were seen focally
in many of the prostatic specimens. Consecutive sections were incubate
d with a chromogranin A antibody to confirm the neuroendocrine phenoty
pe of these cells. A significant correlation (P<0.0001) between the to
tal number of intensely stained VEGF-positive cells and chromogranin A
-positive cells was found. A subpopulation of neuroendocrine-like cell
s also showed intense immunoreactivity for transforming growth factor
alpha (TGF-alpha). A correlation was observed (2p=0.0092) between the
intensity of VEGF and TGF-alpha immunostaining in carcinoma cells whic
h were not of neuroendocrine differentiation. The presence of these tw
o angiogenic factors may aid the neovascularisation of carcinomas and
their increased expression in tumour-associated neuroendocrine cells m
ay contribute to a more aggressive phenotype.